NP93827 Seasonal Influenza Vaccine
In plain English
The notice doesn't say
Who holds it now
Last won by Merck Sharp & Dohme UK Ltd and Aventis Pharma Ltd Trading As Sanofi and Crescent Pharma Limited and 23 more in Sep 2026, for £61.8m.
- NP49426a Transition MedicinesMerck Sharp & Dohme UK Ltd, Aventis Pharma Ltd Trading As Sanofi, Crescent Pharma Limited and 23 more £61.8m
- NP90726m Vedolizumab (Entyvio®)Takeda UK Limited
- HIV MedicinesAmarox Limited, Glenmark Pharmaceuticals Europe Ltd, Lupin Healthcare UK Ltd and 11 more £89.9m
What you're up against
- The last two awards went to different firms: this buyer has changed supplier before.
- 35 different firms won this buyer's 3 awards for this kind of work in 2026.
- It last went for £61.8m in 2026.
- The last award named 26 suppliers: it may be a framework, where many firms are chosen.
The notice as published
Supply of Seasonal Influenza Vaccine.